Two osteoporosis drugs denosumab and teriparatide, when combined together in therapy, produce increase bone density better than treatment with either drug alone. This has been reported by a study, a small clinical trial to be published in journal Lancet.
The study by Joy N Tsai et al has been conducted in Massachusetts General Hospital conducted a 12-month trial in women with postmenopausal osteoporosis.
From September, 2009, to January, 2011, 100 women of age equal to or greater than 45 years were subjected to this randomized, controlled trial. [Read more...]